Company:  DEXCOM INC (DXCM)
Form Type:  10-Q
Filing Date:  11/1/2012 
CIK:  0001093557 
Address:  6340 SEQUENCE DRIVE 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  (858) 200-0200 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$34.68  
Change: 
-1.33 (-3.69%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$2.59B
Description of Business
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Unless the context requires otherwise, the terms �we,� �us,� �our,� the �company,� or �DexCom� refer to DexCom, Inc. and its subsidiaries. Ambulatory Product Line: SEVEN� PLUS, DexCom G4� and DexCom G4� PLATINUM We received approval from the Food and Drug Administration (�FDA�) and commercialized our first product in 2006. In 2007, we received approval and began commercializing our second generation system, the DexCom SEVEN. We no longer market or provide support for the DexCom SEVEN system.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II OTHER INFORMATION
      ITEM 1. LEGAL PROCEEDINGS
      ITEM 1A. RISK FACTORS
      ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      ITEM 3. DEFAULTS UPON SENIOR SECURITIES
      ITEM 4. MINE SAFETY DISCLOSURES
      ITEM 5. OTHER INFORMATION
      ITEM 6. EXHIBITS
    SIGNATURES
  EXHIBIT 31.01
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.02
    CERTIFICATION OF CHIEF FINANCIAL OFFICER
  EXHIBIT 32.01
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 32.02
    CERTIFICATION OF CHIEF FINANCIAL OFFICER
BROKERAGE PARTNERS